Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Current Pharmaceutical Design|November 2, 2016
HDL-Targeting Therapeutics: Past, Present and FutureEmile Zakiev, Ma Feng, Vasily Sukhorukov, et al.Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|January 15, 2019
Glycosylation of human plasma lipoproteins reveals a high level of diversity, which directly impacts their functional propertiesVasily Sukhorukov, Ivan Gudelj, Maja Pučić-Baković, et al.Atherosclerosis Plus|January 16, 2024
Acute myocardial infarction preferentially alters low-abundant, long-chain unsaturated phospholipid and sphingolipid species in plasma high-density lipoprotein subpopulationsMaharajah Ponnaiah, Emile Zakiev, Marie Lhomme, et al.Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|November 6, 2016
Poor glycemic control in type 2 diabetes enhances functional and compositional alterations of small, dense HDL3cLeonardo Gomez Rosso, Marie Lhomme, Tomas Meroño, et al.Journal of Clinical Lipidology|April 21, 2019
Distinct phospholipid and sphingolipid species are linked to altered HDL function in apolipoprotein A-I deficiencyEmile Zakiev, Fabiana Rached, Marie Lhomme, et al.Pageof 1